Sparreboom A - Search Results

1

Relationship of systemic exposure to unbound docetaxel and neutropenia.

Baker SD, Li J, ten Tije AJ, Figg WD, Graveland W, Verweij J, Sparreboom A. Baker SD, et al. Among authors: sparreboom a. Clin Pharmacol Ther. 2005 Jan;77(1):43-53. doi: 10.1016/j.clpt.2004.09.005. Clin Pharmacol Ther. 2005. PMID: 15637530

2

Sensitive determination of docetaxel in human plasma by liquid-liquid extraction and reversed-phase high-performance liquid chromatography.

Loos WJ, Verweij J, Nooter K, Stoter G, Sparreboom A. Loos WJ, et al. Among authors: sparreboom a. J Chromatogr B Biomed Sci Appl. 1997 Jun 6;693(2):437-41. doi: 10.1016/s0378-4347(97)00089-3. J Chromatogr B Biomed Sci Appl. 1997. PMID: 9210450 Clinical Trial.

3

Determination of irinotecan (CPT-11) and its active metabolite SN-38 in human plasma by reversed-phase high-performance liquid chromatography with fluorescence detection.

de Bruijn P, Verweij J, Loos WJ, Nooter K, Stoter G, Sparreboom A. de Bruijn P, et al. Among authors: sparreboom a. J Chromatogr B Biomed Sci Appl. 1997 Sep 26;698(1-2):277-85. doi: 10.1016/s0378-4347(97)00290-9. J Chromatogr B Biomed Sci Appl. 1997. PMID: 9367218 Free article.

4

Differential modulation of cisplatin accumulation in leukocytes and tumor cell lines by the paclitaxel vehicle Cremophor EL.

de Vos AI, Nooter K, Verweij J, Loos WJ, Brouwer E, de Bruijn P, Ruijgrok EJ, van der Burg ME, Stoter G, Sparreboom A. de Vos AI, et al. Among authors: sparreboom a. Ann Oncol. 1997 Nov;8(11):1145-50. doi: 10.1023/a:1008215720081. Ann Oncol. 1997. PMID: 9426335 Free article.

5

Quantitation of Cremophor EL in human plasma samples using a colorimetric dye-binding microassay.

Sparreboom A, Loos WJ, Verweij J, de Vos AI, van der Burg ME, Stoter G, Nooter K. Sparreboom A, et al. Anal Biochem. 1998 Jan 15;255(2):171-5. doi: 10.1006/abio.1997.2467. Anal Biochem. 1998. PMID: 9451500

6

Determination of paclitaxel in human plasma using single solvent extraction prior to isocratic reversed-phase high-performance liquid chromatography with ultraviolet detection.

Sparreboom A, de Bruijn P, Nooter K, Loos WJ, Stoter G, Verweij J. Sparreboom A, et al. J Chromatogr B Biomed Sci Appl. 1998 Jan 23;705(1):159-64. doi: 10.1016/s0378-4347(97)00502-1. J Chromatogr B Biomed Sci Appl. 1998. PMID: 9498685 Clinical Trial.

7

Pharmacokinetics and bioavailability of oral 9-aminocamptothecin capsules in adult patients with solid tumors.

Sparreboom A, de Jonge MJ, Punt CJ, Nooter K, Loos WJ, Porro MG, Verweij J. Sparreboom A, et al. Clin Cancer Res. 1998 Aug;4(8):1915-9. Clin Cancer Res. 1998. PMID: 9717819 Clinical Trial.

8

Disposition of Cremophor EL in humans limits the potential for modulation of the multidrug resistance phenotype in vivo.

Sparreboom A, Verweij J, van der Burg ME, Loos WJ, Brouwer E, Viganò L, Locatelli A, de Vos AI, Nooter K, Stoter G, Gianni L. Sparreboom A, et al. Clin Cancer Res. 1998 Aug;4(8):1937-42. Clin Cancer Res. 1998. PMID: 9717822

9

The development of combination therapy involving camptothecins: a review of preclinical and early clinical studies.

de Jonge MJ, Sparreboom A, Verweij J. de Jonge MJ, et al. Among authors: sparreboom a. Cancer Treat Rev. 1998 Jun;24(3):205-20. doi: 10.1016/s0305-7372(98)90050-0. Cancer Treat Rev. 1998. PMID: 9767735 Review. No abstract available.

10

Irinotecan (CPT-11) metabolism and disposition in cancer patients.

Sparreboom A, de Jonge MJ, de Bruijn P, Brouwer E, Nooter K, Loos WJ, van Alphen RJ, Mathijssen RH, Stoter G, Verweij J. Sparreboom A, et al. Clin Cancer Res. 1998 Nov;4(11):2747-54. Clin Cancer Res. 1998. PMID: 9829738 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

389 results

Search Page

Filters